2cureX AB (publ) (STO:2CUREX)
Sweden · Delayed Price · Currency is SEK 1.614
-0.002 (-0.12%)
Aug 13, 2026, 3:00 PM CET
2cureX AB Market Cap
2cureX AB has a market cap or net worth of 51.56 million as of August 13, 2026. Its market cap has decreased by -0.79% in one year.
Market Cap
51.56M
Enterprise Value
n/a
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.61
ChartMarket Cap Chart
Since November 24, 2017, 2cureX AB's market cap has decreased from 83.32M to 51.56M, a decrease of -38.12%. That is a compound annual growth rate of -5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 51.56M | 299.56% |
| Dec 30, 2025 | 12.90M | 73.70% |
| Dec 30, 2024 | 7.43M | -79.00% |
| Dec 29, 2023 | 35.38M | -75.34% |
| Dec 30, 2022 | 143.46M | -51.13% |
| Dec 30, 2021 | 293.59M | 19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 91.77M |
| OncoZenge AB | 87.24M |
| Ascelia Pharma AB | 77.45M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 75.77M |
| Pila Pharma AB | 59.16M |
| Disruptive Pharma AB | 57.61M |
| Modus Therapeutics Holding AB | 46.83M |